• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Do specific virus-bacteria pairings drive clinical outcomes of pneumonia?

tetano

Editor, Senior Moderator
Clin Microbiol Infect. 2012 Nov 5. doi: 10.1111/1469-0691.12093. [Epub ahead of print]
Do specific virus-bacteria pairings drive clinical outcomes of pneumonia?
McCullers JA.
Source

Department of Pediatrics, University of Tennessee Health Sciences Center, Memphis, TN, USA; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA.
Abstract

Bacterial pneumonia is a common contributor to severe outcomes of influenza. Epidemiological data suggest that the incidence, severity and associated bacterial pathogens differ between epidemics and by geographical location within epidemics. Data from animal models demonstrate that differences in both viral and bacterial strains alter the incidence and outcomes of pneumonia. For influenza viruses, evolutionary changes to specific virulence factors appear to alter the ability of viruses within particular lineages to prime the host for secondary bacterial infection. Although bacterial strains differ considerably in disease potential in the setting of viral co-infection, the bacterial virulence factors underlying this finding are currently unknown. The hypothesis that geographical variation exists in the prevalence of bacterial strains expressing factors that enable efficient disease potentiation during viral epidemics should be considered as one explanation for regional differences in severity. This would have implications for surveillance, vaccine development, and the conduct of clinical trials for the prevention or treatment of pneumonia.

? 2012 The Authors Clinical Microbiology and Infection ? 2012 European Society of Clinical Microbiology and Infectious Diseases.

PMID:
23231363
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23231363
 
Back
Top Bottom